Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Oxprenolol:MRat:24H:Urine:Qn

Known as: ???????????:??????:24 ????:????:?????, Oxprenolol:MRat:24H:Urina:Qn, Oxprenolol:Massa productiesnelheid:24U:Urine:Kwantitatief 
 
National Institutes of Health

Related topics

Related topics

6 relations
OxprenololOxprenolol HydrochlorideSlow TrasicorTevacor
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstracts of the 9th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Berlin, Germany, 10–11 December 2016 (part 1)
s of the 9th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Berlin, Germany, 10–11 December 2016 (part 1) 1… Expand
Is this relevant?
1992
1992
An interactive computer program for randomization analysis of response curves with facilities for multiple comparisons.
An interactive Fortran program, MUCRA, is presented. The program can perform randomization analysis of a completely randomized or… Expand
Is this relevant?
1986
1986
Twenty-four hour effects of oxprenolol oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion
SummaryThe effects of oxprenolol, a non-selective beta-blocker with moderate intrinsic sympathomimetic activity (ISA), given by… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
1986
1986
Antihypertensive activity at rest and during dynamic exercise of oxprenolol oros 16/260 24 hours after dosing: a double-blind comparison with atenolol
 
Is this relevant?
1985
1985
Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
Oxprenolol was administered in single doses by mouth to healthy volunteers either in a polymer-matrix slow-release formulation… Expand
Is this relevant?
1985
1985
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to… Expand
Is this relevant?
1983
1983
Exercise tolerance and echocardiographic assessment of long-term treatment with oxprenolol-bencyclane association in hypertensive patients
 
Is this relevant?
1979
1979
ハロセン麻酔における各種β-遮断薬(propranolol alprenolol oxprenolol CS-359)投与の血行力学的研究
 
Is this relevant?
1976
1976
β-遮断薬 Oxprenolol の健康人に対する作用(補遺)
 
Is this relevant?
1975
1975
β-遮断薬 Oxprenolol の健康人に対する作用
 
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE